201 related articles for article (PubMed ID: 15206110)
1. Gallium and other main group metal compounds as antitumor agents.
Jakupec MA; Keppler BK
Met Ions Biol Syst; 2004; 42():425-62. PubMed ID: 15206110
[TBL] [Abstract][Full Text] [Related]
2. Gallium in cancer treatment.
Jakupec MA; Keppler BK
Curr Top Med Chem; 2004; 4(15):1575-83. PubMed ID: 15579097
[TBL] [Abstract][Full Text] [Related]
3. Gallium Complexes as Anticancer Drugs.
Chitambar CR
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394029
[TBL] [Abstract][Full Text] [Related]
4. Gallium in cancer treatment.
Collery P; Keppler B; Madoulet C; Desoize B
Crit Rev Oncol Hematol; 2002 Jun; 42(3):283-96. PubMed ID: 12050020
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic potential of iron-targeting gallium compounds in human disease: From basic research to clinical application.
Chitambar CR
Pharmacol Res; 2017 Jan; 115():56-64. PubMed ID: 27856328
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of gallium chloride and tris (8-quinolinolato) gallium III on A549 human malignant cell line.
Collery P; Lechenault F; Cazabat A; Juvin E; Khassanova L; Evangelou A; Keppler B
Anticancer Res; 2000; 20(2A):955-8. PubMed ID: 10810380
[TBL] [Abstract][Full Text] [Related]
7. Gallium-pyridoxal isonicotinoyl hydrazone (Ga-PIH), a novel cytotoxic gallium complex. A comparative study with gallium nitrate.
Knorr GM; Chitambar CR
Anticancer Res; 1998; 18(3A):1733-7. PubMed ID: 9673397
[TBL] [Abstract][Full Text] [Related]
8. Non platinum metal complexes as anti-cancer drugs.
Ott I; Gust R
Arch Pharm (Weinheim); 2007 Mar; 340(3):117-26. PubMed ID: 17315259
[TBL] [Abstract][Full Text] [Related]
9. Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins.
Rudnev AV; Foteeva LS; Kowol C; Berger R; Jakupec MA; Arion VB; Timerbaev AR; Keppler BK
J Inorg Biochem; 2006 Nov; 100(11):1819-26. PubMed ID: 16938349
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic mechanisms of gallium nitrate: basic and clinical investigations.
Chitambar CR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 10):39-44. PubMed ID: 15651176
[TBL] [Abstract][Full Text] [Related]
11. Complexes of gallium(III) and other metal ions and their potential in the treatment of neoplasia.
Richardson DR; Lovejoy DB
Expert Opin Investig Drugs; 2000 Jun; 9(6):1257-70. PubMed ID: 11060741
[TBL] [Abstract][Full Text] [Related]
12. Gallium and its competing roles with iron in biological systems.
Chitambar CR
Biochim Biophys Acta; 2016 Aug; 1863(8):2044-53. PubMed ID: 27150508
[TBL] [Abstract][Full Text] [Related]
13. Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.
Chitambar CR; Antholine WE
Antioxid Redox Signal; 2013 Mar; 18(8):956-72. PubMed ID: 22900955
[TBL] [Abstract][Full Text] [Related]
14. Preclinical toxicology and tissue gallium distribution of a novel antitumour gallium compound: tris (8-quinolinolato) gallium (III).
Collery P; Domingo JL; Keppler BK
Anticancer Res; 1996; 16(2):687-91. PubMed ID: 8687115
[TBL] [Abstract][Full Text] [Related]
15. Development of gallium compounds for treatment of lymphoma: gallium maltolate, a novel hydroxypyrone gallium compound, induces apoptosis and circumvents lymphoma cell resistance to gallium nitrate.
Chitambar CR; Purpi DP; Woodliff J; Yang M; Wereley JP
J Pharmacol Exp Ther; 2007 Sep; 322(3):1228-36. PubMed ID: 17600139
[TBL] [Abstract][Full Text] [Related]
16. Gallium compounds as antineoplastic agents.
Chitambar CR
Curr Opin Oncol; 2004 Nov; 16(6):547-52. PubMed ID: 15627016
[TBL] [Abstract][Full Text] [Related]
17. Development of drug resistance to gallium nitrate through modulation of cellular iron uptake.
Chitambar CR; Zivkovic-Gilgenbach Z; Narasimhan J; Antholine WE
Cancer Res; 1990 Aug; 50(15):4468-72. PubMed ID: 2164439
[TBL] [Abstract][Full Text] [Related]
18. Interaction of gallium nitrate with fludarabine and iron chelators: effects on the proliferation of human leukemic HL60 cells.
Lundberg JH; Chitambar CR
Cancer Res; 1990 Oct; 50(20):6466-70. PubMed ID: 1698536
[TBL] [Abstract][Full Text] [Related]
19. Targeting iron-dependent DNA synthesis with gallium and transferrin-gallium.
Chitambar CR; Narasimhan J
Pathobiology; 1991; 59(1):3-10. PubMed ID: 1645976
[TBL] [Abstract][Full Text] [Related]
20. The serum protein binding of pharmacologically active gallium(III) compounds assessed by hyphenated CE-MS techniques.
Groessl M; Bytzek A; Hartinger CG
Electrophoresis; 2009 Aug; 30(15):2720-7. PubMed ID: 19621374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
